What one share of Bioxytran holds
Bioxytran’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.03 |
|---|---|
| Cash and investments | $0.00 |
| Book value | −$0.04 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2011 | $0.05 | −$3.00 | — | — | — | $0.07 |
| 2012 | $0.12 | −$1.00 | — | — | — | $0.11 |
| 2013 | $0.11 | −$0.47 | — | — | — | $0.02 |
| 2014 | $0.06 | −$0.30 | — | — | — | −$0.04 |
| 2015 | $0.03 | −$0.21 | — | — | — | −$0.02 |
| 2016 | $0.01 | −$0.03 | — | — | — | −$0.01 |
| 2017 | $0.00 | −$0.01 | — | — | — | — |
| 2018 | — | −$0.00 | — | — | — | −$0.00 |
| 2019 | — | −$0.02 | — | — | — | −$0.01 |
| 2020 | — | −$0.03 | — | — | — | −$0.02 |
| 2021 | — | −$0.04 | — | — | — | −$0.03 |
| 2022 | — | −$0.02 | — | — | — | −$0.03 |
| 2023 | — | −$0.03 | — | — | — | −$0.02 |
| 2024 | — | −$0.02 | — | — | — | −$0.02 |
| 2025 | — | −$0.02 | — | — | — | −$0.02 |
Common questions about Bioxytran
How much does one share of Bioxytran earn?
Over the last 12 months, Bioxytran lost $0.03 for each share.
Does Bioxytran pay a dividend?
Bioxytran didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Bioxytran’s book value per share?
Bioxytran’s book value is negative (−$0.04 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Bioxytran have?
Each share of Bioxytran has $0.00 of cash and investments, as of June 30, 2026.
Has Bioxytran bought back shares?
Bioxytran’s share count rose about 6423% from 2011 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.